Current Evidence and Practice Guidelines of Systemic Complications of 2022 Mpox Outbreak: A Scoping Review

Cureus. 2023 Sep 22;15(9):e45754. doi: 10.7759/cureus.45754. eCollection 2023 Sep.

Abstract

In May of 2022, the World Health Organization declared a worldwide Mpox virus (MPXV) outbreak. Due to the widespread implementation of vaccination protocols and heightened awareness among the general population, there has been a notable decline in the incidence of Mpox (formerly known as Monkeypox) cases since March 2023. Nevertheless, it is crucial to remember that Mpox has the potential to impact multiple physiological systems in humans, encompassing the cardiovascular, gastrointestinal, ear/nose/throat, and ocular systems. The mortality rate of the Mpox disease is comparatively lower than that of smallpox. However, it is essential to note that this disease can still lead to significant systemic consequences. The specific pathophysiological mechanisms by which the virus affects various physiological systems are now being investigated. Direct inoculation through mucosal damage or intranasal exposure, direct viral toxicity, and lymphatic transmission via the seminal fluid are all viable hypotheses. The prompt recognition of such complications is crucial to decrease morbidity and mortality.

Keywords: monkeypox; monkeypox cardiovascular complications; monkeypox ent complications; monkeypox gastrointestinal complications; monkeypox neurological complications; monkeypox ocular complications; monkeypox outbreak; monkeypox prevention; monkeypox treatment; systemic complications monkeypox.

Publication types

  • Review